LogicBio Therapeutics (LOGC) Misses Q2 EPS by 50c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Loss from operations: -140.8K
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +42.9%
Financial Fact:
Loss from operations: -140.8K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.50).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- InMed Pharmaceuticals gets Nasdaq equity deficiency notice
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
